Bupropion Hydrochloride

Product NDC
71335-0019
11-digit product format
713350019
Labeler code
71335
Product ID
71335-0019_5d34959c-8b87-4468-937c-a4f33ae55db2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Bupropion Hydrochloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA075932
Marketing category
ANDA
Marketing start
2003-11-25
Marketing end
2025-07-31
Substance
BUPROPION HYDROCHLORIDE
Active strength
100 mg/1
Pharmacologic classes
Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71335-0019BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]16Legacy NDC20220630_a97c7e4c-73e1-4017-bab2-bf3482adccbb.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71335-0019-17133500190160 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0019-1) 2015-09-170000-00-00NoNoCurrent
71335-0019-27133500190290 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0019-2) 2018-09-182025-07-31NoNoCurrent
71335-0019-37133500190330 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0019-3) 2019-03-212025-07-31NoNoCurrent
71335-0019-47133500190445 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0019-4) 2015-09-170000-00-00NoNoCurrent
71335-0019-57133500190528 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0019-5) 2015-09-170000-00-00NoNoCurrent
71335-0019-671335001906120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0019-6) 2015-09-170000-00-00NoNoCurrent